A study was recently published in the journal Biomedicine & Pharmacotherapy that identifies a molecule that may protect vision from damage caused by high blood sugar.
Diabetic patients have a high risk of developing diabetic retinopathy. Diabetic retinopathy affects more than 22% of diabetics worldwide. The condition is a result of high blood sugar levels that have caused inflammation, which results in damaged neurons and blood vessels within the retina. This has the potential of causing permanent vision loss.
Researchers examined the Ac2-26 peptide using experimental models that mimic the human eye. Researchers found that Ac2-26 reduced inflammation and oxidative stress and also shielded mitochondrial function. The combination of these actions prevented the death of neurons that had been exposed to high blood sugar levels.
Researchers are hopeful that the discovery of this peptide can open the door to stopping the progression of diabetic neuropathy and protect the vulnerable neurons by creating new therapies.












